SPI-1005 - Is this Ebselen-based drug a Menieres Miracle? Menieres Without The Spin , Substack, 17 July 2026, Primary Clinical Trial Database: Sound Pharmaceuticals
Large Phase 3 randomized controlled trials specific to endometriosis and GLP-1 medications are described as being in "nascent stages." Until they are completed, we are working with biological plausibility, mechanistic evidence, and self-reported survey data, valuable but incomplete
Injectable forms deliver consistent, predictable semaglutide levels and demonstrate stronger weight-loss outcomes in clinical trials
Other data show the medications support nerve repair in conditions like multiple sclerosis (MS)
But they also didn't get thin probably because there are specific cells in the vomit center that do not induce vomiting but are critical to weight loss
Treatment includes personalized dose adjustments, side-effect support, and guidance for maintaining your results when medically appropriate